Aseptic Manufacturing: A Roadmap to Excellence

In recent years, numerous weaknesses within the manufacture of sterile injectable drugs have been identified. As a result, nearly one-third of the industry’s sterile injectable manufacturing capacity is off line because of quality issues, according to a Congressional report.

Download (1.5MB)